AMPK activation improves recovery from pneumonia-induced lung injury via reduction of er-stress and apoptosis in alveolar epithelial cells

• Published in: Respiratory research Vol. 24; no. 1; pp. 185 - 15
• Main Authors: Becker, Jr, Eugene, Husain, Maroof, Bone, Nathaniel, Smith, Samuel, Morris, Peter, Zmijewski, Jaroslaw W
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 12.07.2023; BioMed Central; BMC
• Subjects: Accumulation; Alveolar Epithelial Cells; Alveoli; AMP-activated protein kinase; AMP-Activated Protein Kinases; Analysis; Animal models; Animals; Antibodies; Apoptosis; Bacteria; Bacterial diseases; Bacterial infections; Bacterial pneumonia; Bioenergetics; Bronchopulmonary infection; Complications and side effects; Cytokines; Efferocytosis; Endoplasmic reticulum; Epithelial cells; Epithelium; Flow cytometry; Glycogen Synthase Kinase 3 beta; Health aspects; Hospitals; Inactivation; Injury prevention; Intensive care units; Kinases; Laboratories; Leukocytes (neutrophilic); Lung Injury - drug therapy; Lungs; Macrophages; Metabolism; Metformin; Mice; Mitochondria; Mortality; Nitric oxide; Nosocomial infections; Pathogens; Phosphates; Phosphorylation; Pneumonia; Prevention; Protein kinases; Proteins; Recovery; Risk factors; Sepsis; Statistical significance; Stress; Therapeutic applications; United Kingdom; Minneapolis Minnesota; United States > US; Efferocytosis; Mitochondria; Pneumonia; Bacterial infections; Endoplasmic reticulum; Alveolar epithelial cells
• ISSN: 1465-993X; 1465-9921; 1465-993X; 1465-9921
• DOI: 10.1186/s12931-023-02483-6

Bacterial pneumonia and related lung injury are among the most frequent causes of mortality in intensive care units, but also inflict serious and prolonged respiratory complications among survivors. Given that endoplasmic reticulum (ER) stress is a hallmark of sepsis-related alveolar epithelial cell (AEC) dysfunction, we tested if AMP-activated protein kinase (AMPK) affects recovery from ER stress and apoptosis of AECs during post-bacterial infection. In a murine model of lung injury by P. aeruginosa non-lethal infection, therapeutic interventions included AMPK activator metformin or GSK-3β inhibitor Tideglusib for 96 h. Recovery from AEC injury was evidenced by accumulation of soluble T-1α (AEC Type 1 marker) in BAL fluids along with fluorescence analysis of ER-stress (CHOP) and apoptosis (TUNEL) in lung sections. AMPK phosphorylation status and mediators of ER stress were determined via Immunoblot analysis from lung homogenates. Macrophage-dependent clearance of apoptotic cells was determined using flow cytometry assay. P. aeruginosa-induced lung injury resulted in accumulation of neutrophils and cellular debris in the alveolar space along with persistent (96 h) ER-stress and apoptosis of AECs. While lung infection triggered AMPK inactivation (de-phosphorylation of Thr172-AMPK), metformin and Tideglusib promptly restored the AMPK activation status. In post infected mice, AMPK activation reduced indices of lung injury, ER stress and related apoptosis of AECs, as early as 24 h post administration of AMPK activators. In addition, we demonstrate that the extent of apoptotic cell accumulation is also dependent on AMPK-mediated clearance of apoptotic cells by macrophages. Our study provides important insights into AMPK function in the preservation of AEC viability after bacterial infection, in particular due reduction of ER-stress and apoptosis, thereby promoting effective recovery from lung injury after pneumonia.